B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines

Cancer Res. 1996 Jan 1;56(1):11-5.

Abstract

In vitro propagation of tumor-specific CTLs, to be used for identification of tumor antigens (Ag) and/or adoptive immunotherapy, is hampered by the need of large amounts of professional antigen-presenting cells (APC) used for periodical cycles of restimulation. We evaluated whether RMA T lymphoma cells, stably transfected with the cDNA encoding for the B7.1 costimulatory molecule, provided the activation signals to CD8+ T lymphocytes in the absence of professional APC and CD4+ helper cells. We demonstrate here that long-term CD8+ cell lines can be efficiently propagated in vitro by repeated cycles of stimulation with tumor cells stably expressing B7.1. Professional APC and CD4+ helper cells are not required as far as interleukin 2 is exogenously provided. Furthermore, CD8+ blasts needed both signal 1 (Ag in the contest of the MHC molecule) and signal 2 (interaction of costimulatory molecules) for restimulation. T cell blasts in the presence of signal 1 or 2 only still retained their effector potential but did not undergo clonal expansion. These results are very promising for further applications of specific immunotherapies in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen Presentation / immunology*
  • B7-1 Antigen / biosynthesis*
  • B7-1 Antigen / genetics
  • CD8-Positive T-Lymphocytes / immunology*
  • Coculture Techniques
  • Cytotoxicity, Immunologic*
  • DNA, Complementary / genetics
  • Gene Expression
  • Humans
  • Lymphocyte Activation / immunology
  • Lymphoma, T-Cell / genetics
  • Lymphoma, T-Cell / immunology*
  • Tumor Cells, Cultured

Substances

  • B7-1 Antigen
  • DNA, Complementary